Girao Tiago
CIK 0001618670
Chief Financial OfficerDirector
Filings
7
Latest Apr 24, 2026
Issuers covered
2
Showing
7 of 7
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -17.0% | -17.0% | -17.0% | -17.0% |
| 90 days | - | - | - | - | - | - |
| 180 days | - | - | - | - | - | - |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Girao Tiago has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| LABP | Landos Biopharma, Inc. | 4 | May 23, 2024 |
| IMVT | Immunovant, Inc. | 3 | Apr 24, 2026 |
All filings
7 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|